InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,222.68
(
0.16%
)
US TECH 100
17,650.00
(
0.05%
)
Dow Jones
39,512.84
(
0.32%
)
Brent Oil
82.59
(
0.00%
)
Bitcoin
61,346.10
(
0.90%
)
Post# of 20617
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

jtaylor68

Send PM Follow Ignore
Followers 2
Posts 736
Boards Moderated 0
Alias Born 05/16/2017

jtaylor68

Re: Biotech Pharmer post# 11918

Wednesday, 10/18/2017 2:56:57 PM

Wednesday, October 18, 2017 2:56:57 PM

Post# of 20617
Again, you apparently don't understand that an NDA is nothing suspicious and that Damaj is obliged to adhere to it. I can't stress that enough. NDAs are routine business practice. Consequently there is nothing to come clean. Their manufacturer has a pending OTC ANDA and INNV's management is not allowed to talk about anything related to their agreement. That's it. Very simple, very straightforward, nothing suspicious.
Nobody is grasping at straws as you like to put it.

Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up